Author(s): Rampone B, Schiavone B, Martino A, Viviano C, Confuorto G, Rampone B, Schiavone B, Martino A, Viviano C, Confuorto G
Abstract Share this page
Abstract Hepatocellular carcinoma (HCC) still remains a considerable challenge for surgeons. Surgery, including liver transplantation, is the most important therapeutic approach for patients with this disease. HCC is frequently diagnosed at advanced stages and has a poor prognosis with a high mortality rate even when surgical resection has been considered potentially curative. This brief report summarizes the current status of the management of this malignancy and includes a short description of new pharmacological approaches in HCC treatment.
This article was published in World J Gastroenterol
and referenced in Journal of Cancer Science & Therapy